Anti-LEPROTL1 monoclonal antibody

Pre-made anti-LEPROTL1 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to LEPROTL1/LEPROTL1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1081-Ab-1/ GM-Tg-hg-IP1081-Ab-2Anti-Human LEPROTL1 monoclonal antibodyHuman
GM-Tg-rg-IP1081-Ab-1/ GM-Tg-rg-IP1081-Ab-2Anti-Rat LEPROTL1 monoclonal antibodyRat
GM-Tg-mg-IP1081-Ab-1/ GM-Tg-mg-IP1081-Ab-2Anti-Mouse LEPROTL1 monoclonal antibodyMouse
GM-Tg-cynog-IP1081-Ab-1/ GM-Tg-cynog-IP1081-Ab-2Anti-Cynomolgus/ Rhesus macaque LEPROTL1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1081-Ab-1/ GM-Tg-felg-IP1081-Ab-2Anti-Feline LEPROTL1 monoclonal antibodyFeline
GM-Tg-cang-IP1081-Ab-1/ GM-Tg-cang-IP1081-Ab-2Anti-Canine LEPROTL1 monoclonal antibodyCanine
GM-Tg-bovg-IP1081-Ab-1/ GM-Tg-bovg-IP1081-Ab-2Anti-Bovine LEPROTL1 monoclonal antibodyBovine
GM-Tg-equg-IP1081-Ab-1/ GM-Tg-equg-IP1081-Ab-2Anti-Equine LEPROTL1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1081-Ab-1/ GM-Tg-hg-IP1081-Ab-2; GM-Tg-rg-IP1081-Ab-1/ GM-Tg-rg-IP1081-Ab-2;
GM-Tg-mg-IP1081-Ab-1/ GM-Tg-mg-IP1081-Ab-2; GM-Tg-cynog-IP1081-Ab-1/ GM-Tg-cynog-IP1081-Ab-2;
GM-Tg-felg-IP1081-Ab-1/ GM-Tg-felg-IP1081-Ab-2; GM-Tg-cang-IP1081-Ab-1/ GM-Tg-cang-IP1081-Ab-2;
GM-Tg-bovg-IP1081-Ab-1/ GM-Tg-bovg-IP1081-Ab-2; GM-Tg-equg-IP1081-Ab-1/ GM-Tg-equg-IP1081-Ab-2
Products NameAnti-LEPROTL1 monoclonal antibody
Formatmab
Target NameLEPROTL1
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-LEPROTL1 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1081-Ag-1Recombinant multi-species LERL1/ LEPROTL1/ HSPC112 protein
    ORF Viral VectorpGMLP003268human LEPROTL1 Lentivirus plasmid
    ORF Viral VectorvGMLP003268human LEPROTL1 Lentivirus particle
    ORF Viral VectorpGMLPm002368mouse Leprotl1 Lentivirus plasmid
    ORF Viral VectorvGMLPm002368mouse Leprotl1 Lentivirus particle


    Target information

    Target IDGM-IP1081
    Target NameLEPROTL1
    Gene ID23484,68192,361160,694012,475601,101093431,513036,100062721
    Gene Symbol and Synonyms1110067H13Rik,1520402O14Rik,HSPC112,LEPROTL1,my047,Vps55
    Uniprot AccessionO95214,Q6PDU4,Q32PD8
    Uniprot Entry NameLERL1_HUMAN,LERL1_RAT,LERL1_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000104660
    Target ClassificationN/A

    The target: LEPROTL1, gene name: LEPROTL1, also named as HSPC112, Vps55, my047. Enables identical protein binding activity. Predicted to be involved in late endosome to vacuole transport via multivesicular body sorting pathway and negative regulation of growth hormone receptor signaling pathway. Predicted to be integral component of membrane. Predicted to be active in endosome. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.